Andere Sprachen Agilent Technologies, Inc.

Aktien

929138

US00846U1016

A

Medizinische Ausrüstung

Markt geschlossen - NYSE Andere Börsenplätze 22:00:03 17.07.2026			Nachbörslich 02:00:00
131,46 ^USD	-3,41 %		132,44	+0,75 %

14.07.	Agilent Technologies erhält FDA-Zulassung für PD-L1 IHC 28-8 pharmDx bei Plattenepithelkarzinom der Speiseröhre sowie Magen-, gastroösophagealem Übergangs- und Adenokarzinom der Speiseröhre	CI
14.07.	Agilent erhält FDA-Zulassung für PD-L1-Test zur Steuerung des Einsatzes von Opdivo von Bristol Myers bei Magen-Darm-Krebserkrankungen	MT

Andere Sprachen

14.07.	Agilent Technologies Receives Fda Approval for Pd-L1 Ihc 28-8 Pharmdx in Esophageal Squamous Cell Carcinoma, Gastric, Gastroesophageal Junction, and Esophageal Adenocarcinoma
14.07.	Agilent Wins FDA Approval for PD-L1 Test to Guide Bristol Myers' Opdivo Use in GI Cancers
14.07.	Agilent Receives FDA Approval for PD-L1 IHC 28-8 pharmDx in Esophageal Squamous Cell Carcinoma (ESCC), Gastric, Gastroesophageal Junction (GEJ), and Esophageal Adenocarcinoma
08.07.	Agilent Technologies Inc. Expands Altura Portfolio with Inert Size Exclusion and Plrp-S Columns for Biotherapeutic Analysis
08.07.	Agilent Expands Altura Portfolio with Inert Size Exclusion and PLRP-S Columns for Biotherapeutic Analysis
01.07.	Agilent Technologies Launches Xcelligence RTCA Esight AI Module
01.07.	Agilent Launches AI-Driven Analysis Module for Agilent xCELLigence RTCA eSight
26.06.	Analyst recommendations: Crocs, Dell, On Semiconductor, Qualcomm, Micron…
25.06.	Agilent Technologies, Inc. Closes $600 Million Private Placement Of 4.900% Senior Notes Due 2032
25.06.	Agilent Technologies, Inc. (NYSE:A) completed the acquisition of Biocare Medical, LLC from an investor group led by Excellere Capital Fund III LP, a fund managed by Excellere Capital Management LLC and GHO Capital Partners LLP.
25.06.	Agilent Technologies Completes Purchase of Biocare Medical From Excellere-Led Investor Group
25.06.	Agilent Completes Acquisition of Biocare Medical
03.06.	Trading Day: War clouds and tech wobbles
03.06.	Agilent Technologies Partners With OpenAI, Boston Consulting for AI Deployment
03.06.	Agilent, OpenAI, BCG Collaborate to Accelerate Customer-Focused, AI-Driven Scientific Innovation
03.06.	Agilent Technologies Inc., OpenAI , and Boston Consulting Group Collaborate to Accelerate Customer-Focused, Ai-Driven Scientific Innovation
03.06.	Bourse : 135 USD pour une action SpaceX, gros contrat pour Eiffage
03.06.	L'Europe veut revenir dans la course technologique
02.06.	Trading Day: New high? Still a buy
02.06.	Agilent Technologies' Cancer Test Gets Expanded Approval From FDA
02.06.	Agilent Gets US FDA Clearance for Expanded Use of Cancer Test on Dako Omnis Platform
02.06.	Agilent Receives FDA Approval for Expanded Use of PD-L1 IHC 22C3 pharmDx on Dako Omnis in Esophageal Squamous Cell Carcinoma, Triple-Negative Breast Cancer, Cervical Cancer, and Gastric or Gastroesophageal Junction Adenocarcinoma
02.06.	Agilent Technologies Receives FDA Approval For Expanded Use Of PD-L1 IHC 22C3 PharmDx On Dako Omnis In Esophageal Squamous Cell Carcinoma, Triple-Negative Breast Cancer, Cervical Cancer, And Gastric Or Gastroesophageal Junction Adenocarcinoma
01.06.	Agilent Technologies : and Sound Analytics Collaborate to Advance LC/MS Workflows for Drug Metabolism Research
01.06.	Trading Day: Talks + tech = boom!